Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2020
Sep. 30, 2019
Current Assets    
Cash and cash equivalents $ 374.0 $ 399.0
Trade receivables, net 292.8 217.4
Receivables from long-term manufacturing contracts 187.3 181.1
Inventories, net 423.3 176.6
Prepaid expenses and other current assets 86.7 49.1
Other current assets 86.7 49.1
Total current assets 1,364.1 1,023.2
Property, plant, and equipment, net 348.7 140.3
Operating lease right-of-use assets 165.0 0.0
Intangible assets, net 1,101.3 454.9
Goodwill 1,133.5 578.0
Other long-term assets 78.1 32.2
Total Assets 4,190.7 2,228.6
Current Liabilities    
Trade accounts payable 297.9 236.2
Liabilities from long-term manufacturing contracts and advances 176.6 158.2
Current portion of long-term debt 46.7 0.0
Accrued compensation 78.2 73.2
Other current liabilities 205.8 121.7
Total current liabilities 805.2 589.3
Long-term debt 1,826.6 619.5
Accrued pension and postretirement healthcare 157.9 131.3
Operating lease liabilities 130.8 0.0
Deferred Income Tax Liabilities, Net 187.5 73.6
Other long-term liabilities 55.7 45.1
Total Liabilities 3,163.7 1,458.8
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 63.9 shares issued, 74.7 and 62.7 shares outstanding) 0.0 0.0
Additional paid-in capital 716.3 345.3
Retained earnings 496.4 599.5
Treasury stock (1.1 and 1.2 shares) (45.4) (50.1)
Accumulated other comprehensive loss (158.3) (140.6)
Hillenbrand Shareholders’ Equity 1,009.0 754.1
Noncontrolling interests 18.0 15.7
Total Shareholders’ Equity 1,027.0 769.8
Total Liabilities and Shareholders’ Equity $ 4,190.7 $ 2,228.6